UTHealth study focuses on how gene-environment interactions impact cocaine use disorder

NewsGuard 100/100 Score

Studying the effect of environmental stressors on the development of cocaine use is the focus of a $2.6 million award from the National Institutes of Health (NIH) to researchers at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

Called Collaborative Case-Control Initiative in Cocaine Addiction, the study will look at two stressors in particular - trauma exposure and HIV infection - in combination with the genetic profile of people who are addicted to cocaine.

"The significance of the genetic findings will be further investigated using the UTHealth Brain Collection for Research in Psychiatric Disorders," said Consuelo Walss-Bass, Ph.D., associate professor in the Department of Psychiatry and Behavioral Sciences at McGovern Medical School and one of the study's three lead principal investigators. "These studies will help further the understanding of how gene-environment interactions impact the severity of cocaine use disorder and lead to development of more tailored and targeted treatments for this chronic and global public health problem."

Lead investigators include Joy Schmitz, Ph.D., the Louis A. Faillace, M.D. Professor and director of the Center for Neurobehavioral Research on Addictions at McGovern Medical School; and Rodrigo Grassi-Oliveira, Ph.D., of the Pontificia Universidade Catolica in Rio Grande do Sul, Brazil.

The five-year study of Brazilian subjects will compare 1,000 people with cocaine addiction to 1,000 controls.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients